2TZ.F Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 14.35%
- Fundamental score
- -
Is 2TZ.F undervalued?
Graham numberThe Graham number of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited fundamental analysis
No fundamental analysis for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited yet.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was …
Full company profileFinancial statements of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited are not available yet.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited dividends
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has not paid dividends in the last 4 fiscal years.
Who owns Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Insiders 9.16%
- Institutions 0.13%
- Public & others 90.71%
- Free float 426M
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited company profile
- Company name
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Ticker
- 2TZ.F
- ISIN
- CNE100000924
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 3,890
- Fiscal year end
- December
- Address
- No. 17, Baidi Road, Tianjin, China, 300193
- Phone
- 86 22 2702 0892
- Website
- jydrt.com.cn
About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited management
9- Ms. Lei WangChairman of the Board · born 1971
- Mr. Jian MaChief Financial Officer · born 1978
- Mr. Hong ZhouDeputy GM, Chief Engineer & Executive Director · born 1970
- Mr. Min GuoExecutive Director · born 1971
- Mr. Yu ZhangChief Manufacturing Officer · born 1973
- Mr. Mingjie ShangEmployee Director · born 1969
- Ms. Yan JiaoSecretary to the Board of Directors · born 1977
- Tang ChaoAccounting Supervisor
- Mr. Hong ChenExecutive Vice President · born 1971